Lessons Learned from COVID-19 Clinical Trials
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists...
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
Lab Data in Clinical Research: 4 Ways It Drives Better Outcomes While most life sciences teams know...
Diabetes is a complex disease that affects over 37 million Americans, or 11% of the population, and...
As we honor our military service members this Veterans Day, we take time to reflect on how we can...
In a recent report, the Centers for Disease Control and Prevention (CDC) found that four out of...
Author: Emery Niemiec, Director, Partners & Alliance at HealthVerity Privacy preserving record...
HealthVerity’s journey from an unknown startup to a major disrupter in the Healthcare industry ...
The Inside Story Behind MOM, the Maternal Outcomes Masterset In the Spring of 2021, HealthVerity...
Written by Emery Niemiec I recently attended the 2022 INFORMS Business Analytics Conference and had...
In Season 2 of The Pitt, Dr. Santos accepts an AI-drafted clinical note and moves on. It’s one of those quiet, believable moments the show does well but the consequences ripple. Small errors slip into the chart. On television it’s a tidy story point ...